Synthesis of Ag/AgCl/Fe-S plasmonic catalyst for bisphenol A degradation in heterogeneous photo-Fenton system under visible light irradiation

A novel plasmonic photo‐Fenton catalyst of Ag/AgCl/Fe‐S was synthesized by ion exchange and photoreduction methods.The obtained catalyst was characterized by X‐ray diffraction,X‐ray photoelectron spectroscopy,scanning electron microscope imaging,and Brunauer‐Emmett‐Teller measurements.Moreover,the photocatalytic activity of Ag/AgCl/Fe‐S was investigated for its degradation activity towards bisphenol A(BPA)as target pollutant under visible light irradiation.The effects of H2O2concentration,pH value,illumination intensity,and catalyst dosage on BPA degradation were examined.Our results indicated that the Ag/AgCl material was successfully loaded onto Fe‐sepiolite and showed a high photocatalytic activity under illumination by visible light.Furthermore,active species capture experiments were performed to explore the photocatalytic mechanism of the Ag/AgCl/Fe‐S in this heterogeneous photo‐Fenton process,where the major active species included hydroxyl radicals(?OH)and holes(h+).

Dysregulated STAT1 gain-of-function:Pathogen-free autoimmunity and fungal infection

Inborn errors of the signal transducer and activator of transcription 1(STAT1)result in four types of immunodeficiency disease with varying degrees of impaired STAT1 function:autosomal recessive(AR)complete STAT1 deficiency,AR partial STAT1 deficiency,autosomal dominant(AD)STAT1 deficiency,and AD STAT1 gain-of-function(STAT1-GOF).Of which,the STAT1-GOF mutations promote a clinical syndrome of immune dysregulation characterized by recurrent infections,especially chronic mucocutaneous candidiasis(CMC)and Talaromyces marneffei infection and predisposition to humoral autoimmunity.STAT1-GOF mutations lead to enhanced phosphorylation of STAT1(pSTAT1),delayed dephosphorylation,and impaired nuclear dephosphorylation.As a result,the development of T helper(Th)17 cells is impaired,limiting the production of interleukin(IL)-17,which plays an important role in antifungal immunity.Additionally,mutations can also cause a decrease in the proportion of CD4^(+),CD8^(+),and natural killer(NK)cells.Recent research demonstrated that in the absence of overt infection,STAT-GOF mice can disrupt naïve CD4^(+)T cell homeostasis and promote expansion and differentiation of abnormal T-follicular helper/T-helper 1-like(Tfh/Th1-like)T cells and germinal center-like(GC-like)B cells,and thus reminds us of the complex molecular mechanism of autoimmune disease with/without fungal infection,which may further involve specific clinical treatment including antifungal and anti-autoimmunity therapies.In addition,sex and location of mutation were also associated with the clinical phenotype.Individuals with DNA binding domain(DBD)mutations had a higher prevalence of autoimmunity and aberrant B cell activation.Disrupted CD4^(+)T cell homeostasis occurred sooner and more robustly in females,highlighting the importance of specific treatment to normalize STAT1 expression and restore immune tolerance in patients with STAT1-GOF syndrome.Herein,we provide a comprehensive review of STAT1-GOF aiming to further clarify the regulatory mechanism of cellular and humoral immune deficiency in patients with fungal infection with or without autoimmunity.